0001493152-25-017841.txt : 20251014 0001493152-25-017841.hdr.sgml : 20251014 20251010182934 ACCESSION NUMBER: 0001493152-25-017841 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251014 DATE AS OF CHANGE: 20251010 EFFECTIVENESS DATE: 20251014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Palomino Laboratories Inc. CENTRAL INDEX KEY: 0001938569 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 881619619 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-560582 FILM NUMBER: 251388933 BUSINESS ADDRESS: STREET 1: 12 E. 49TH STREET STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (917) 200-3734 MAIL ADDRESS: STREET 1: 12 E. 49TH STREET STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: Unite Acquisition 3 Corp. DATE OF NAME CHANGE: 20220719 D 1 primary_doc.xml X0708 D LIVE 0001938569 Palomino Laboratories Inc. 313 BRYANT COURT PALO ALTO CA CALIFORNIA 94301 704-756-2981 DELAWARE None Unite Acquisition 3 Corp. Corporation true 2022 Jeffrey Shealy 313 Bryant Court Palo Alto CA CALIFORNIA 94301 Executive Officer Director Promoter Steven DenBaars 313 Bryant Court Palo Alto CA CALIFORNIA 94301 Executive Officer Director Promoter Richard Ogawa 313 Bryant Court Palo Alto CA CALIFORNIA 94301 Executive Officer Director Jason Tu 313 Bryant Court Palo Alto CA CALIFORNIA 94301 Director Nathan Pierra 12 E. 49th Street 11th Floor New York NY NEW YORK 10017 Executive Officer Director Promoter Other Technology Decline to Disclose 06b false 2025-09-29 false true Units, with each unit consisting of 1 share of common stock and a warrant to purchase 1 share of common stock true This offering was held in connection with the acquisition of the Issuer by Palomino Laboratories Inc. (renamed Rhino Subsidiary Inc.) through a reverse merger. 13500 Laidlaw & Company (UK) Ltd 000119037 None None 16 Berkeley St Suite 7.09 London X0 UNITED KINGDOM W1J 8DZ All States true 12846000 11601022 1244978 false 116 1243923 0 Does not include $35,000 non-accountable expense reimbursement. 0 false Palomino Laboratories Inc. /s/ Jeffrey Shealy Jeffrey Shealy President and CEO 2025-10-10